The identification of BRP, an anti-obesity peptide, showcases the transformative role of AI in drug discovery and its ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

BRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...

With spring break approaching, now is the perfect time to focus on shedding unwanted fat and achieving a leaner physique.

Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, Ratings reports. Two analysts ...

If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...

Discover how peptides are transforming medical treatments, metabolic conditions and more with fewer side effects than ...

March 7, 2025 (Investorideas.com Newswire) Investorideas.com, a recognized top 100 investment site for stock news announces ...

increase in the L cells density and in glucagon-like peptide 1 production, both acting on the NOS/NO pathway). Our data support, for the first time in the context of vascular dysfunction, the concept ...

This maximizes GLP-1 therapy benefits and improves patient outcomes. Patient Education Needs to Meet Patients Where They Are Despite their proven benefits, GLP-1s are also known for their ...

suggesting that enhancing GLP-1 signaling in the brain could lessen cocaine cravings. Researchers pinpointed a specific neural pathway involving GLP-1-producing neurons located in the nucleus tractus ...

effects that suggest that increasing central GLP-1 signaling could reduce cocaine seeking. Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox ...